{
    "clinical_study": {
        "@rank": "120994", 
        "arm_group": [
            {
                "arm_group_label": "Ibuprofen (Brufen\u00ae)", 
                "arm_group_type": "Active Comparator", 
                "description": "film-coated tablet"
            }, 
            {
                "arm_group_label": "Ibuprofen (Nurofen Immedia\u00ae)", 
                "arm_group_type": "Active Comparator", 
                "description": "film-coated tablet"
            }, 
            {
                "arm_group_label": "Ibuprofen+caffeine", 
                "arm_group_type": "Experimental", 
                "description": "fixed-dose-combination (FDC)"
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate the relative bioavailability of ibuprofen from a (FDC) film-coated tablet of\n      ibuprofen and caffeine vs. a tablet of ibuprofen (Brufen\u00ae) and a tablet of ibuprofen\n      lysinate (Nurofen Immedia\u00ae)."
        }, 
        "brief_title": "Relative Bioavailability of Ibuprofen From a Single Fixed Dose Combination Tablet of Ibuprofen and Caffeine Compared to Single Tablets of Ibuprofen and Ibuprofen Lysinate", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Healthy male and female subjects\n\n          -  Age 18 to 50 years\n\n          -  Body mass index (BMI) 18.5 to 29.9 kg/m2\n\n          -  Subjects must be able to understand and comply with study requirements\n\n        Exclusion criteria:\n\n        - Any relevant deviation from healthy conditions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01879371", 
            "org_study_id": "1335.2", 
            "secondary_id": "2013-000990-66"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ibuprofen+caffeine", 
                "description": "oral dose", 
                "intervention_name": "Ibuprofen+caffeine FDC", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ibuprofen (Nurofen Immedia\u00ae)", 
                "description": "oral dose", 
                "intervention_name": "Ibuprofen (Nurofen Immedia\u00ae)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ibuprofen (Brufen\u00ae)", 
                "description": "oral dose", 
                "intervention_name": "Ibuprofen (Brufen\u00ae)", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Caffeine", 
                "Ibuprofen"
            ]
        }, 
        "lastchanged_date": "August 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ingelheim", 
                    "country": "Germany"
                }, 
                "name": "1335.2.1 Boehringer Ingelheim Investigational Site"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "3", 
        "official_title": "Relative Bioavailability of Ibuprofen From a Fixed Dose Combination (FDC) Tablet of Ibuprofen 400 mg and Caffeine 100 mg Compared to a Tablet of Ibuprofen 400 mg and a Tablet of Ibuprofen Lysinate 400 mg Following Oral Administration in Healthy Male and Female Subjects (an Open-label, Randomised, Single-dose, Three-period Crossover Study)", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "AUC0-tz (area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point)", 
                "safety_issue": "No", 
                "time_frame": "2 days"
            }, 
            {
                "measure": "Cmax (maximum measured concentration of the analyte in plasma)", 
                "safety_issue": "No", 
                "time_frame": "2 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01879371"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "AUC0-infinity  (area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity)", 
            "safety_issue": "No", 
            "time_frame": "2 days"
        }, 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}